Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 192

1.

Secondary loss of response to mepolizumab in severe eosinophilic asthma.

Cormier M, Chaboillez S, Lemiere C.

J Allergy Clin Immunol Pract. 2019 Aug 14. pii: S2213-2198(19)30711-1. doi: 10.1016/j.jaip.2019.08.005. [Epub ahead of print] No abstract available.

PMID:
31421278
2.

Outcomes following mepolizumab treatment discontinuation: real-world experience from an open-label trial.

Ortega H, Lemiere C, Llanos JP, Forshag M, Price R, Albers F, Yancey S, Castro M.

Allergy Asthma Clin Immunol. 2019 Jun 10;15:37. doi: 10.1186/s13223-019-0348-z. eCollection 2019.

3.

Novel clinical scores for occupational asthma due to exposure to high-molecular-weight agents.

Taghiakbari M, Pralong JA, Lemière C, Moullec G, Saha-Chaudhuri P, Cartier A, Castano R, Suarthana E.

Occup Environ Med. 2019 Jul;76(7):495-501. doi: 10.1136/oemed-2018-105593. Epub 2019 Apr 20. Erratum in: Occup Environ Med. 2019 Nov;76(11):872.

PMID:
31005857
4.

Omalizumab in patients with severe asthma and persistent sputum eosinophilia.

Mukherjee M, Kjarsgaard M, Radford K, Huang C, Leigh R, Dorscheid DR, Lemiere C, Boulet LP, Waserman S, Martin J, Nair P.

Allergy Asthma Clin Immunol. 2019 Apr 3;15:21. doi: 10.1186/s13223-019-0337-2. eCollection 2019.

5.

Impact of Low Dose Chlorine Inhalation in Healthy Humans: A Pilot Study.

Ojanguren I, Chaboillez S, Cloutier Y, Panariti A, McGovern TK, Martin JG, Lemiere C.

J Investig Allergol Clin Immunol. 2019;29(4):323-325. doi: 10.18176/jiaci.0396. Epub 2019 Apr 8. No abstract available.

6.

Genetic variants with gene regulatory effects are associated with diisocyanate-induced asthma.

Bernstein DI, Lummus ZL, Kesavalu B, Yao J, Kottyan L, Miller D, Cartier A, Cruz MJ, Lemiere C, Muñoz X, Quirce S, Tarlo S, Sastre J, Boulet LP, Weirauch MT, Kaufman K.

J Allergy Clin Immunol. 2018 Sep;142(3):959-969. doi: 10.1016/j.jaci.2018.06.022. Epub 2018 Jun 30.

PMID:
29969634
7.

Between-Visit Variability in FEV1 as a Diagnostic Test for Asthma in Adults.

Dean BW, Birnie EE, Whitmore GA, Vandemheen KL, Boulet LP, FitzGerald JM, Ainslie M, Gupta S, Lemiere C, Field SK, McIvor RA, Hernandez P, Mayers I, Aaron SD; Canadian Respiratory Research Network.

Ann Am Thorac Soc. 2018 Sep;15(9):1039-1046. doi: 10.1513/AnnalsATS.201803-211OC.

PMID:
29877740
8.

Development of a graphical tool to measure medication adherence in asthma patients: A mixed-methods pilot study.

Yousif A, Lemière C, Cartier A, Forget A, Blais L.

J Asthma. 2019 May;56(5):543-552. doi: 10.1080/02770903.2018.1471702. Epub 2018 Jun 8.

PMID:
29746201
9.

Low blood eosinophil counts are not always a reliable marker of clinical response to mepolizumab in severe asthma.

Ojanguren I, Chaboillez S, Lemiere C.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):2151-2153. doi: 10.1016/j.jaip.2018.04.014. Epub 2018 Apr 30. No abstract available.

PMID:
29715561
10.

Correction: Clinical and inflammatory characteristics of Asthma-COPD overlap in workers with occupational asthma.

Ojanguren I, Moullec G, Hobeika J, Miravitlles M, Lemiere C.

PLoS One. 2018 Apr 4;13(4):e0195648. doi: 10.1371/journal.pone.0195648. eCollection 2018.

11.

Clinical and inflammatory characteristics of Asthma-COPD overlap in workers with occupational asthma.

Ojanguren I, Moullec G, Hobeika J, Miravitlles M, Lemiere C.

PLoS One. 2018 Mar 2;13(3):e0193144. doi: 10.1371/journal.pone.0193144. eCollection 2018. Erratum in: PLoS One. 2018 Apr 4;13(4):e0195648.

12.

Chlorine Inhalation Challenge in Humans: Development of a New Closed-Circuit Methodology.

Ojanguren I, Cloutier Y, Chaboillez S, Lemiere C.

Arch Bronconeumol. 2018 Aug;54(8):440-442. doi: 10.1016/j.arbres.2017.11.005. Epub 2017 Dec 16. English, Spanish. No abstract available.

13.

Long-Acting β2-Agonists and Risk of Hypertensive Disorders of Pregnancy: A Cohort Study.

Blais L, Kettani FZ, Forget A, Beauchesne MF, Lemière C, Rey E.

J Allergy Clin Immunol Pract. 2018 Mar - Apr;6(2):555-561.e2. doi: 10.1016/j.jaip.2017.07.004. Epub 2017 Aug 26.

PMID:
28847655
14.

Thymic Stromal Lymphopoietin: A Promising Target in the Treatment of Asthma?

Ojanguren I, Martin JG, Lemiere C.

Arch Bronconeumol. 2017 Oct;53(10):545-546. doi: 10.1016/j.arbres.2017.05.015. Epub 2017 Jun 20. English, Spanish. No abstract available.

15.

Characterization of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: A Qualitative Analysis.

Rodrigue C, Beauchesne MF, Mallette V, Lemière C, Larivée P, Blais L.

COPD. 2017 Jun;14(3):330-338. doi: 10.1080/15412555.2017.1318841. Epub 2017 May 11.

PMID:
28494181
16.

Diagnostic Accuracy of Inflammatory Markers for Diagnosing Occupational Asthma.

Racine G, Castano R, Cartier A, Lemiere C.

J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1371-1377.e1. doi: 10.1016/j.jaip.2017.02.001. Epub 2017 Mar 9.

PMID:
28286155
17.

Airway Hyperresponsiveness in Asthma: Measurement and Clinical Relevance.

Nair P, Martin JG, Cockcroft DC, Dolovich M, Lemiere C, Boulet LP, O'Byrne PM.

J Allergy Clin Immunol Pract. 2017 May - Jun;5(3):649-659.e2. doi: 10.1016/j.jaip.2016.11.030. Epub 2017 Feb 2. Review.

PMID:
28163029
18.

Reevaluation of Diagnosis in Adults With Physician-Diagnosed Asthma.

Aaron SD, Vandemheen KL, FitzGerald JM, Ainslie M, Gupta S, Lemière C, Field SK, McIvor RA, Hernandez P, Mayers I, Mulpuru S, Alvarez GG, Pakhale S, Mallick R, Boulet LP; Canadian Respiratory Research Network.

JAMA. 2017 Jan 17;317(3):269-279. doi: 10.1001/jama.2016.19627.

PMID:
28114551
19.

To Ban or Not to Ban? Regulating Dual Practice in Palestine.

Alaref J, Awwad J, Araujo E, Lemiere C, Hillis SA, Özaltin E.

Health Syst Reform. 2017 Jan 2;3(1):42-55. doi: 10.1080/23288604.2016.1272980.

PMID:
31514710
20.

Prospective Impact of Psychiatric Disorders on Employment Status and Health Care Use in Patients Investigated for Occupational Asthma.

Lavoie KL, Favreau H, Paine NJ, Lemière C, Joseph M, Gagnon-Chauvin A, Cartier A, Bacon SL.

J Occup Environ Med. 2016 Dec;58(12):1196-1201.

PMID:
27930478
21.

What do health workers in Timor-Leste want, know and do? Findings from a national health labour market survey.

Hou X, Witter S, Zaman RU, Engelhardt K, Hafidz F, Julia F, Lemiere C, Sullivan EB, Saldanha E, Palu T, Lievens T.

Hum Resour Health. 2016 Nov 18;14(1):69.

22.

Understanding Health Workers' Job Preferences to Improve Rural Retention in Timor-Leste: Findings from a Discrete Choice Experiment.

Smitz MF, Witter S, Lemiere C, Eozenou PH, Lievens T, Zaman RU, Engelhardt K, Hou X.

PLoS One. 2016 Nov 15;11(11):e0165940. doi: 10.1371/journal.pone.0165940. eCollection 2016.

23.

Assessing adherence to inhaled corticosteroids in asthma patients using an integrated measure based on primary and secondary adherence.

Blais L, Kettani FZ, Forget A, Beauchesne MF, Lemière C, Ducharme FM.

Eur J Clin Pharmacol. 2017 Jan;73(1):91-97. doi: 10.1007/s00228-016-2139-5. Epub 2016 Oct 1.

PMID:
27695918
24.

Reply.

Lemiere C, Pralong JA, Cartier A.

J Allergy Clin Immunol. 2016 Oct;138(4):1239-1240. doi: 10.1016/j.jaci.2016.07.005. Epub 2016 Aug 25. No abstract available.

PMID:
27569748
25.

Exacerbation risk in severe asthma is stratified by inflammatory phenotype using longitudinal measures of sputum eosinophils.

Walsh CJ, Zaihra T, Benedetti A, Fugère C, Olivenstein R, Lemière C, Hamid Q, Martin JG.

Clin Exp Allergy. 2016 Oct;46(10):1291-302. doi: 10.1111/cea.12762. Epub 2016 Jun 27.

PMID:
27214328
26.

Reslizumab for Inadequately Controlled Asthma With Elevated Blood Eosinophil Levels: A Randomized Phase 3 Study.

Bjermer L, Lemiere C, Maspero J, Weiss S, Zangrilli J, Germinaro M.

Chest. 2016 Oct;150(4):789-798. doi: 10.1016/j.chest.2016.03.032. Epub 2016 Apr 4.

27.

Adverse events among COPD patients treated with long-acting anticholinergics and β2-agonists in an outpatient respiratory clinic.

Rodrigue C, Beauchesne MF, Savaria F, Forget A, Lemière C, Larivée P, Blais L; RESP Investigators.

Respir Med. 2016 Apr;113:65-73. doi: 10.1016/j.rmed.2016.02.002. Epub 2016 Feb 9.

28.

Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.

Sehmi R, Smith SG, Kjarsgaard M, Radford K, Boulet LP, Lemiere C, Prazma CM, Ortega H, Martin JG, Nair P.

Clin Exp Allergy. 2016 Jun;46(6):793-802. doi: 10.1111/cea.12695.

PMID:
26685004
29.

Investigation of occupational asthma: Do clinicians fail to identify relevant occupational exposures?

de Olim C, Bégin D, Boulet LP, Cartier A, Gérin M, Lemière C.

Can Respir J. 2015 Nov-Dec;22(6):341-7. Epub 2015 Sep 30.

30.

Do asthma patients with panic disorder really have worse asthma? A comparison of physiological and psychological responses to a methacholine challenge.

Boudreau M, Lavoie KL, Cartier A, Trutshnigg B, Morizio A, Lemière C, Bacon SL.

Respir Med. 2015 Oct;109(10):1250-6. doi: 10.1016/j.rmed.2015.09.002. Epub 2015 Sep 9.

31.

Association between patterns of leisure time physical activity and asthma control in adult patients.

Bacon SL, Lemiere C, Moullec G, Ninot G, Pepin V, Lavoie KL.

BMJ Open Respir Res. 2015 Jul 24;2(1):e000083. doi: 10.1136/bmjresp-2015-000083. eCollection 2015.

32.

Predictive value of nonspecific bronchial responsiveness in occupational asthma.

Pralong JA, Lemière C, Rochat T, L'Archevêque J, Labrecque M, Cartier A.

J Allergy Clin Immunol. 2016 Feb;137(2):412-6. doi: 10.1016/j.jaci.2015.06.026. Epub 2015 Jul 26.

PMID:
26220529
33.

Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia.

Smith SG, Chen R, Kjarsgaard M, Huang C, Oliveria JP, O'Byrne PM, Gauvreau GM, Boulet LP, Lemiere C, Martin J, Nair P, Sehmi R.

J Allergy Clin Immunol. 2016 Jan;137(1):75-86.e8. doi: 10.1016/j.jaci.2015.05.037. Epub 2015 Jul 17.

PMID:
26194544
34.

Asthma exacerbations during the first trimester of pregnancy and congenital malformations: revisiting the association in a large representative cohort.

Blais L, Kettani FZ, Forget A, Beauchesne MF, Lemière C.

Thorax. 2015 Jul;70(7):647-52. doi: 10.1136/thoraxjnl-2014-206634. Epub 2015 Apr 17.

PMID:
25888364
35.

Is drug insurance status an effect modifier in epidemiologic database studies? The case of maternal asthma and major congenital malformations.

Blais L, Kettani FZ, Forget A, Beauchesne MF, Lemière C.

Birth Defects Res A Clin Mol Teratol. 2015 Dec;103(12):995-1002. doi: 10.1002/bdra.23366. Epub 2015 Apr 6.

PMID:
25846426
36.

Accuracy of the days' supply and the number of refills allowed recorded in Québec prescription claims databases for inhaled corticosteroids.

Blais L, Vilain A, Kettani FZ, Forget A, Lalonde G, Beauchesne MF, Ducharme FM, Lemière C.

BMJ Open. 2014 Nov 28;4(11):e005903. doi: 10.1136/bmjopen-2014-005903.

37.

Efficacy of brief motivational interviewing to improve adherence to inhaled corticosteroids among adult asthmatics: results from a randomized controlled pilot feasibility trial.

Lavoie KL, Moullec G, Lemiere C, Blais L, Labrecque M, Beauchesne MF, Pepin V, Cartier A, Bacon SL.

Patient Prefer Adherence. 2014 Nov 10;8:1555-69. doi: 10.2147/PPA.S66966. eCollection 2014.

38.

Outcome of work-related asthma exacerbations in Quebec and Ontario.

Lemière C, To T, de Olim C, Ribeiro M, Liss G, Lougheed MD, Hoy R, Forget A, Blais L, Zhu J, Tarlo SM.

Eur Respir J. 2015 Jan;45(1):266-8. doi: 10.1183/09031936.00096114. Epub 2014 Oct 30. No abstract available.

39.

Advanced diagnostic studies: exhaled breath and sputum analyses.

Lemière C.

J Occup Environ Med. 2014 Oct;56 Suppl 10:S45-8. doi: 10.1097/JOM.0000000000000286. Review.

PMID:
25285976
40.

Occupational asthma phenotypes identified by increased fractional exhaled nitric oxide after exposure to causal agents.

Lemiere C, NGuyen S, Sava F, D'Alpaos V, Huaux F, Vandenplas O.

J Allergy Clin Immunol. 2014 Nov;134(5):1063-7. doi: 10.1016/j.jaci.2014.08.017. Epub 2014 Sep 26.

PMID:
25262466
41.

The development and test re-test reliability of a work-related asthma screening questionnaire.

Killorn KR, Dostaler SM, Olajos-Clow J, Turcotte SE, Minard JP, Holness DL, Kudla I, Lemière C, To T, Liss G, Tarlo SM, Lougheed MD.

J Asthma. 2015 Apr;52(3):279-88. doi: 10.3109/02770903.2014.956892. Epub 2014 Sep 9.

PMID:
25180965
42.

Systemic corticosteroids for the treatment of asthma exacerbations during and outside of pregnancy in an acute-care setting.

Cossette B, Beauchesne MF, Forget A, Lemière C, Larivée P, Rey É, Couturier M, Rodrigue C, Blais L.

Respir Med. 2014 Sep;108(9):1260-7. doi: 10.1016/j.rmed.2014.07.001. Epub 2014 Jul 11.

43.

Secondary prevention of work-exacerbated asthma: evaluation of the questionnaire prediction model.

Pralong JA, Moullec G, Dorribo V, Lemiere C, Suarthana E.

J Occup Environ Med. 2014 Jul;56(7):e55-7. doi: 10.1097/JOM.0000000000000218. No abstract available.

PMID:
24988109
44.

Exhaled nitric oxide as a screening tool for occupational asthma.

Lemiere C.

Int J Tuberc Lung Dis. 2014 Jun;18(6):634. doi: 10.5588/ijtld.14.0299. No abstract available.

PMID:
24903930
45.

Determinants Of Oral corticosteroid Responsiveness in Wheezing Asthmatic Youth (DOORWAY): protocol for a prospective multicentre cohort study of children with acute moderate-to-severe asthma exacerbations.

Ducharme FM, Zemek R, Gravel J, Chalut D, Poonai N, Laberge S, Quach C, Krajinovic M, Guimont C, Lemière C, Guertin MC.

BMJ Open. 2014 Apr 7;4(4):e004699. doi: 10.1136/bmjopen-2013-004699.

46.

Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy.

Cossette B, Beauchesne MF, Forget A, Lemière C, Larivée P, Rey E, Blais L.

Ann Allergy Asthma Immunol. 2014 May;112(5):459-64. doi: 10.1016/j.anai.2014.02.010. Epub 2014 Mar 19.

PMID:
24656659
47.

Occupational asthma.

Tarlo SM, Lemiere C.

N Engl J Med. 2014 Feb 13;370(7):640-9. doi: 10.1056/NEJMra1301758. Review.

PMID:
24521110
48.

Why do health labour market forces matter?

McPake B, Maeda A, Araújo EC, Lemiere C, El Maghraby A, Cometto G.

Bull World Health Organ. 2013 Nov 1;91(11):841-6. doi: 10.2471/BLT.13.118794.

49.

When to suspect occupational asthma.

Lemière C.

Can Respir J. 2013 Nov-Dec;20(6):442-4. Review.

50.

Safety and efficacy of an oral CCR3 antagonist in patients with asthma and eosinophilic bronchitis: a randomized, placebo-controlled clinical trial.

Neighbour H, Boulet LP, Lemiere C, Sehmi R, Leigh R, Sousa AR, Martin J, Dallow N, Gilbert J, Allen A, Hall D, Nair P.

Clin Exp Allergy. 2014 Apr;44(4):508-16. doi: 10.1111/cea.12244.

PMID:
24286456

Supplemental Content

Loading ...
Support Center